vs
Side-by-side financial comparison of Purple Innovation, Inc. (PRPL) and PTC THERAPEUTICS, INC. (PTCT). Click either name above to swap in a different company.
PTC THERAPEUTICS, INC. is the larger business by last-quarter revenue ($164.7M vs $140.7M, roughly 1.2× Purple Innovation, Inc.). Purple Innovation, Inc. runs the higher net margin — -2.3% vs -82.0%, a 79.7% gap on every dollar of revenue. On growth, Purple Innovation, Inc. posted the faster year-over-year revenue change (9.1% vs -22.7%). Purple Innovation, Inc. produced more free cash flow last quarter ($-7.8M vs $-36.6M). Over the past eight quarters, Purple Innovation, Inc.'s revenue compounded faster (8.3% CAGR vs -11.5%).
Purple Carrot is a Needham, Massachusetts-based, and 100% plant-based meal kit company. Founded by Andy Levitt, it offers both prepared meals as well as meal kits to subscribers weekly. As stated in a 2022 article in Cosmopolitan, “each Purple Carrot meal kit results in 72% less carbon being released into the atmosphere as compared to the standard American meal.”
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.
PRPL vs PTCT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $140.7M | $164.7M |
| Net Profit | $-3.2M | $-135.0M |
| Gross Margin | 41.9% | — |
| Operating Margin | -1.6% | -43.3% |
| Net Margin | -2.3% | -82.0% |
| Revenue YoY | 9.1% | -22.7% |
| Net Profit YoY | 62.1% | -104.8% |
| EPS (diluted) | $0.03 | $-1.63 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $140.7M | $164.7M | ||
| Q3 25 | $118.8M | $211.0M | ||
| Q2 25 | $105.1M | $178.9M | ||
| Q1 25 | $104.2M | $1.2B | ||
| Q4 24 | $129.0M | $213.2M | ||
| Q3 24 | $118.6M | $196.8M | ||
| Q2 24 | $120.3M | $186.7M | ||
| Q1 24 | $120.0M | $210.1M |
| Q4 25 | $-3.2M | $-135.0M | ||
| Q3 25 | $-11.7M | $15.9M | ||
| Q2 25 | $-17.3M | $-64.8M | ||
| Q1 25 | $-19.1M | $866.6M | ||
| Q4 24 | $-8.5M | $-65.9M | ||
| Q3 24 | $-39.2M | $-106.7M | ||
| Q2 24 | $27.0K | $-99.2M | ||
| Q1 24 | $-50.2M | $-91.6M |
| Q4 25 | 41.9% | — | ||
| Q3 25 | 42.8% | — | ||
| Q2 25 | 35.9% | — | ||
| Q1 25 | 39.4% | — | ||
| Q4 24 | 42.9% | — | ||
| Q3 24 | 29.7% | — | ||
| Q2 24 | 40.7% | — | ||
| Q1 24 | 34.8% | — |
| Q4 25 | -1.6% | -43.3% | ||
| Q3 25 | -10.2% | 1.4% | ||
| Q2 25 | -13.5% | -19.5% | ||
| Q1 25 | -13.9% | 82.5% | ||
| Q4 24 | -6.0% | -76.2% | ||
| Q3 24 | -39.5% | -27.7% | ||
| Q2 24 | -12.1% | -21.5% | ||
| Q1 24 | -19.3% | -21.6% |
| Q4 25 | -2.3% | -82.0% | ||
| Q3 25 | -9.9% | 7.5% | ||
| Q2 25 | -16.5% | -36.3% | ||
| Q1 25 | -18.4% | 73.7% | ||
| Q4 24 | -6.6% | -30.9% | ||
| Q3 24 | -33.1% | -54.2% | ||
| Q2 24 | 0.0% | -53.1% | ||
| Q1 24 | -41.8% | -43.6% |
| Q4 25 | $0.03 | $-1.63 | ||
| Q3 25 | $0.11 | $0.20 | ||
| Q2 25 | $0.16 | $-0.83 | ||
| Q1 25 | $0.18 | $10.04 | ||
| Q4 24 | $0.08 | $-0.85 | ||
| Q3 24 | $0.36 | $-1.39 | ||
| Q2 24 | $0.00 | $-1.29 | ||
| Q1 24 | $0.47 | $-1.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $24.3M | $1.9B |
| Total DebtLower is stronger | $126.7M | — |
| Stockholders' EquityBook value | $-29.7M | $-205.3M |
| Total Assets | $296.3M | $2.9B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $24.3M | $1.9B | ||
| Q3 25 | $32.4M | $1.7B | ||
| Q2 25 | $34.2M | $2.0B | ||
| Q1 25 | $21.6M | $2.0B | ||
| Q4 24 | $29.0M | $1.1B | ||
| Q3 24 | $23.4M | $1.0B | ||
| Q2 24 | $23.4M | $1.1B | ||
| Q1 24 | $34.5M | $884.8M |
| Q4 25 | $126.7M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $70.7M | — | ||
| Q3 24 | $50.8M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $-29.7M | $-205.3M | ||
| Q3 25 | $-26.9M | $-155.8M | ||
| Q2 25 | $-15.6M | $-206.5M | ||
| Q1 25 | $1.3M | $-185.8M | ||
| Q4 24 | $20.2M | $-1.1B | ||
| Q3 24 | $28.0M | $-1.1B | ||
| Q2 24 | $66.4M | $-980.2M | ||
| Q1 24 | $65.5M | $-893.9M |
| Q4 25 | $296.3M | $2.9B | ||
| Q3 25 | $302.1M | $2.6B | ||
| Q2 25 | $303.8M | $2.6B | ||
| Q1 25 | $293.8M | $2.7B | ||
| Q4 24 | $307.8M | $1.7B | ||
| Q3 24 | $309.3M | $1.8B | ||
| Q2 24 | $362.1M | $1.9B | ||
| Q1 24 | $382.1M | $1.8B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 3.50× | — | ||
| Q3 24 | 1.82× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-5.8M | $-34.3M |
| Free Cash FlowOCF − Capex | $-7.8M | $-36.6M |
| FCF MarginFCF / Revenue | -5.5% | -22.3% |
| Capex IntensityCapex / Revenue | 1.4% | 1.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-41.9M | $702.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-5.8M | $-34.3M | ||
| Q3 25 | $-968.0K | $-66.3M | ||
| Q2 25 | $-4.0M | $-58.3M | ||
| Q1 25 | $-23.1M | $870.1M | ||
| Q4 24 | $6.8M | $-30.0M | ||
| Q3 24 | $1.1M | $-77.0M | ||
| Q2 24 | $-8.9M | $-71.5M | ||
| Q1 24 | $-16.8M | $70.8M |
| Q4 25 | $-7.8M | $-36.6M | ||
| Q3 25 | $-1.8M | $-69.7M | ||
| Q2 25 | $-7.0M | $-59.6M | ||
| Q1 25 | $-25.3M | $868.4M | ||
| Q4 24 | $5.7M | $-33.8M | ||
| Q3 24 | $101.0K | $-77.5M | ||
| Q2 24 | $-11.0M | $-78.8M | ||
| Q1 24 | $-19.9M | $61.2M |
| Q4 25 | -5.5% | -22.3% | ||
| Q3 25 | -1.5% | -33.1% | ||
| Q2 25 | -6.6% | -33.3% | ||
| Q1 25 | -24.3% | 73.8% | ||
| Q4 24 | 4.4% | -15.8% | ||
| Q3 24 | 0.1% | -39.4% | ||
| Q2 24 | -9.2% | -42.2% | ||
| Q1 24 | -16.5% | 29.1% |
| Q4 25 | 1.4% | 1.4% | ||
| Q3 25 | 0.7% | 1.6% | ||
| Q2 25 | 2.8% | 0.7% | ||
| Q1 25 | 2.2% | 0.1% | ||
| Q4 24 | 0.8% | 1.8% | ||
| Q3 24 | 0.9% | 0.3% | ||
| Q2 24 | 1.7% | 4.0% | ||
| Q1 24 | 2.5% | 4.6% |
| Q4 25 | — | — | ||
| Q3 25 | — | -4.17× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.00× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -330.22× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PRPL
| Cost Of Revenues | $81.7M | 58% |
| Other | $59.0M | 42% |
PTCT
Segment breakdown not available.
